U.S. RESEARCH ROUNDUP- Capital One Financial, Netflix, Regeneron Pharmaceuticals
22/01/2025 06:40
Jan 22 (Reuters) - Wall Street securities analysts revised their ratings and price
targets on several U.S.-listed companies, including Capital One Financial, Netflix and Regeneron
Pharmaceuticals on Wednesday.
HIGHLIGHTS
* Capital One Financial Corp COF.N : JP Morgan raises target price to $198 from $186
* Intra-Cellular Therapies Inc ITCI.O : RBC cuts to sector perform from outperform
* Netflix Inc NFLX.O : Piper Sandler raises target price to $1,100 from $950
* Regeneron Pharmaceuticals Inc REGN.O : RBC cuts target price to $1,059 from $1,184
* Vertex Pharmaceuticals Inc VRTX.O : RBC raises target price to $402 from $401
Following is a summary of research actions on U.S. companies reported by Reuters on Wednesday.
Stock entries are in alphabetical order.
* Axsome Therapeutics Inc AXSM.O : RBC cuts target price to $139 from $140
* BOK Financial Corp BOKF.O : Raymond James raises target price to $125 from $121
* BOK Financial Corp BOKF.O : RBC raises target price to $120 from $115
* Capital One Financial Corp COF.N : JP Morgan raises target price to $198 from $186
* Capital One Financial Corp COF.N : RBC raises target price to $200 from $190
* Charles Schwab Corp SCHW.N : Piper Sandler raises target price to $78 from $70
* Charles Schwab Corp SCHW.N : Raymond James raises target price to $88 from $86
* Charles Schwab Corp SCHW.N : Truist Securities raises target price to $90 from $86
* Cibus Inc CBUS.O : Canaccord Genuity cuts target price to $18 from $20
* Community Financial System Inc CBU.N : Raymond James raises target price to $73 from $67
* FB Financial Corp FBK.N : Piper Sandler raises target price to $58 from $57
* Gilead GILD.O : RBC raises target price to $84 from $83
* Incyte INCY.O : RBC cuts target price to $70 from $75
* Interactive Brokers Group Inc IBKR.O : Piper Sandler raises target to $210 from $200
* Intra-Cellular Therapies Inc ITCI.O : RBC cuts to sector perform from outperform
* Intra-Cellular Therapies Inc ITCI.O : RBC raises target price to $132 from $108
* Mondelez MDLZ.O : JP Morgan cuts target price to $68 from $81
* Netflix Inc NFLX.O : Piper Sandler raises target price to $1,100 from $950
* Neurocrine Biosciences Inc NBIX.O : RBC cuts target price to $154 from $159
* Old National Bancorp ONB.O : RBC raises target price to $26 from $24
* PTC Therapeutics Inc PTCT.O : RBC raises target price to $60 from $58
* Radnet Inc RDNT.O : Raymond James cuts target price to $85 from $90
* Regeneron Pharmaceuticals Inc REGN.O : RBC cuts target price to $1,059 from $1,184
* Sage Therapeutics Inc SAGE.O : RBC raises target price to $6 from $5
* Snowflake Inc SNOW.N : Wedbush raises target price to $210 from $190
* Sun Country Airlines SNCY.O : JP Morgan initiates with overweight rating; target $23
* Vertex Pharmaceuticals Inc VRTX.O : RBC raises target price to $402 from $401
* Zions Bancorporation NA ZION.O : JP Morgan raises target price to $65 from $62
* Zions Bancorporation NA ZION.O : RBC raises target price to $63 from $61
(Compiled by Bengaluru Newsroom)
((Diaries@thomsonreuters.com))